Search Within

Gabriella D'Andrea-Carlino

  1. "Behavioral Sciences Service"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (12)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (25)
  2. Behavioral Sciences Service (25)
  3. Breast Medicine Service (25)
  4. Department of Medicine (25)
  5. Psychiatry and Behavioral Sciences, Department of (25)
  6. Solid Tumor Oncology Division (25)

More Groups

People
  1. Clifford Hudis (24)
  2. Teresa Gilewski (24)
  3. Larry Norton (22)
  4. Diana Lake (18)
  5. Chau Dang (17)
  6. Maura Dickler (17)

More People

Years
  1. 2018 (1)
  2. 2015 (3)
  3. 2014 (2)
  4. 2013 (1)
  5. 2012 (1)
  6. 2011 (3)

More Years

Publications
  1. Cancer Research (7)
  2. Journal of Clinical Oncology (5)
  3. Clinical Breast Cancer (4)
  4. Clinical Cancer Research (4)
  5. Breast Cancer Research and Treatment (3)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (11)
  2. American Society of Clinical Oncology (5)
  3. Elsevier Inc. (4)
  4. Springer (3)
  5. John Wiley & Sons (1)
  6. Oxford University Press (1)

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prolonged dose-dense (DD) epirubicin and cyclophosphamide (EC) followed by paclitaxel (T) in breast cancer (BCA) is feasible
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Preliminary cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification
    Journal Article

    Seidman, A. D.; Fornier, M. N.; Esteva, F. J.; Tan, L.; Kaptain, S.; Bach, A.; Panageas, K. S.; Arroyo, C.; Valero, V.; Currie, V.; more...
    Journal of Clinical Oncology (2001)

    Fulltext@MSK | Save
  • Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma
    Journal Article

    Fornier, M. N.; Seidman, A. D.; Theodoulou, M.; Moynahan, M. E.; Currie, V.; Moasser, M.; Sklarin, N.; Gilewski, T.; D'Andrea, G.; Salvaggio, R.; more...
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer
    Journal Article

    D'Andrea, G.; Fennelly, D.; Norton, L.; Baselga, J.; Gilewski, T.; Hudis, C.; Moynahan, M. E.; Raptis, G.; Sklarin, N.; Surbone, A.; more...
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save